Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors
Pheton Holdings (NASDAQ:PTHL), a healthcare solution provider specializing in brachytherapy treatment planning systems, has issued an official statement addressing recent market volatility and misleading rumors. The company's stock experienced a significant decline following a speculative article published by The Bear Cave on July 29, 2025.
The company categorically denies any involvement in stock price manipulation or rumors regarding a potential acquisition by Gilead Sciences. Pheton confirms it has had no contact with Gilead and plans to engage with Nasdaq and regulatory bodies to address the situation. Management emphasizes its commitment to transparency and maintaining strong corporate governance standards.
Pheton Holdings (NASDAQ:PTHL), un fornitore di soluzioni sanitarie specializzato in sistemi di pianificazione del trattamento di brachiterapia, ha rilasciato una dichiarazione ufficiale in merito alla recente volatilit脿 del mercato e alle voci fuorvianti. Il titolo dell'azienda ha subito un calo significativo a seguito di un articolo speculativo pubblicato da The Bear Cave il 29 luglio 2025.
L'azienda nega categoricamente qualsiasi coinvolgimento nella manipolazione del prezzo delle azioni o voci riguardanti una possibile acquisizione da parte di Gilead Sciences. Pheton conferma di non aver avuto contatti con Gilead e intende collaborare con Nasdaq e le autorit脿 di regolamentazione per affrontare la situazione. La direzione sottolinea il suo impegno per la trasparenza e il mantenimento di elevati standard di governance aziendale.
Pheton Holdings (NASDAQ:PTHL), un proveedor de soluciones de salud especializado en sistemas de planificaci贸n de tratamientos de braquiterapia, ha emitido una declaraci贸n oficial en respuesta a la reciente volatilidad del mercado y rumores enga帽osos. Las acciones de la compa帽铆a sufrieron una ca铆da significativa tras un art铆culo especulativo publicado por The Bear Cave el 29 de julio de 2025.
La empresa niega categ贸ricamente cualquier implicaci贸n en la manipulaci贸n del precio de las acciones o rumores sobre una posible adquisici贸n por parte de Gilead Sciences. Pheton confirma que no ha tenido contacto con Gilead y planea colaborar con Nasdaq y los organismos reguladores para abordar la situaci贸n. La direcci贸n enfatiza su compromiso con la transparencia y el mantenimiento de altos est谩ndares de gobernanza corporativa.
Pheton Holdings (NASDAQ:PTHL)電� 攴检爲旃橂 瓿勴殟 鞁滌姢韰滌潉 鞝勲鞙茧 頃橂姅 鞚橂 靻旊（靺� 鞝滉车鞐呾泊搿滌劀, 斓滉芳 鞁滌灔 氤�霃欖劚瓿� 鞓ろ暣鞚� 靻岇臧� 鞛堧姅 耄ǜ鞐� 雽�頃� 瓿奠嫕 靹彪獏鞚� 氚滍憸頄堨姷雼堧嫟. 須岇偓 欤缄皜電� 2025雲� 7鞗� 29鞚� The Bear Cave鞐愳劀 瓴岇灛頃� 於旍浮靹� 旮办偓 鞚错泟 韥矊 頃橂澖頄堨姷雼堧嫟.
须岇偓电� 欤缄皜 臁办瀾 鞐半（雮� Gilead Sciences鞚� 鞚胳垬 臧�電レ劚鞐� 雽�頃� 耄ǜ毳� 鞝勲┐ 攵�鞚�頃╇媹雼�. Pheton鞚� Gilead鞕� 鞏措枲頃� 鞝戩磯霃� 鞐嗢棃鞙茧┌, 鞚措矆 靷儨 頃搓舶鞚� 鞙勴暣 Nasdaq 氚� 攴滌牅 旮瓣磤瓿� 順戨牓頃� 瓿勴殟鞛勳潉 頇曥澑頄堨姷雼堧嫟. 瓴届榿歆勳潃 韴獏靹� 鞙犾鞕� 臧曤牓頃� 旮办梾 瓯半矂雱岇姢 旮办 欷�靾橂ゼ 臧曥“頄堨姷雼堧嫟.
Pheton Holdings (NASDAQ:PTHL), un fournisseur de solutions de sant茅 sp茅cialis茅 dans les syst猫mes de planification des traitements de curieth茅rapie, a publi茅 une d茅claration officielle concernant la r茅cente volatilit茅 du march茅 et les rumeurs trompeuses. Le cours de l'action de la soci茅t茅 a connu une baisse significative apr猫s un article sp茅culatif publi茅 par The Bear Cave le 29 juillet 2025.
L'entreprise nie cat茅goriquement toute implication dans une manipulation du cours de l'action ou les rumeurs concernant une 茅ventuelle acquisition par Gilead Sciences. Pheton confirme n鈥檃voir eu aucun contact avec Gilead et pr茅voit de collaborer avec le Nasdaq et les autorit茅s r茅glementaires pour g茅rer la situation. La direction souligne son engagement envers la transparence et le maintien de normes 茅lev茅es de gouvernance d鈥檈ntreprise.
Pheton Holdings (NASDAQ:PTHL), ein Anbieter von Gesundheitsl枚sungen, der sich auf Brachytherapie-Behandlungsplanungssysteme spezialisiert hat, hat eine offizielle Stellungnahme zur j眉ngsten Marktvolatilit盲t und irref眉hrenden Ger眉chten ver枚ffentlicht. Die Aktien des Unternehmens erlitten nach einem spekulativen Artikel, der am 29. Juli 2025 von The Bear Cave ver枚ffentlicht wurde, einen erheblichen Kursr眉ckgang.
Das Unternehmen weist jegliche Beteiligung an Kursmanipulationen oder Ger眉chte 眉ber eine m枚gliche 脺bernahme durch Gilead Sciences kategorisch zur眉ck. Pheton best盲tigt, keinen Kontakt mit Gilead gehabt zu haben, und plant, mit der Nasdaq sowie den Aufsichtsbeh枚rden zusammenzuarbeiten, um die Situation zu kl盲ren. Das Management betont sein Engagement f眉r Transparenz und die Einhaltung hoher Standards der Unternehmensf眉hrung.
- None.
- Share price experienced extraordinary and unexpected decline
- Company subject to potentially damaging speculative article questioning stock activity
- Potential market manipulation affecting company's stock
Insights
Pheton issues defensive statement addressing severe stock decline triggered by false acquisition rumors, denying any involvement in market manipulation.
This press release represents a crisis communication response from Pheton Holdings following what appears to be a significant stock price decline. The company is explicitly addressing an article by The Bear Cave that suggested Pheton's stock may have been artificially inflated by false acquisition rumors involving Gilead Sciences.
The language used is notably defensive and emphatic, with management "unequivocally and categorically" denying involvement in any stock manipulation. This forceful denial suggests the company is concerned about potential regulatory scrutiny or shareholder litigation. The statement that Pheton "has had no contact with Gilead" is particularly direct, leaving no room for ambiguity.
Notably, Pheton indicates it plans to engage with Nasdaq and regulators to hold "responsible parties to the scheme accountable" - language that suggests they believe there was an organized attempt to manipulate their stock. This proactive stance implies they're positioning themselves as victims rather than perpetrators.
The company's emphasis on "internal controls" suggests they may be conducting an internal investigation to ensure no employees were involved. The remainder of the release follows crisis communication best practices by attempting to refocus attention on the company's long-term prospects while acknowledging shareholder concerns.
The timing is significant - responding just three days after The Bear Cave publication indicates the company recognizes the seriousness of these allegations and the need for immediate damage control to prevent further stock decline and preserve investor confidence.
BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the 鈥淐ompany,鈥� 鈥渨e,鈥� 鈥渙ur鈥� or 鈥淧heton鈥�), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today issued the following statements in response to recent market volatility and a third-party publication that has raised questions and concerns among shareholders.
Over the past few days, shares of Pheton have experienced an extraordinary and unexpected decline in its share price, which the Company believes may have been triggered by a speculative article published by The Bear Cave on July 29, 2025. The article asserts that Pheton鈥檚 share price may have been influenced by false rumors of a potential acquisition by Gilead Sciences, Inc. (鈥淕ilead鈥�).
Management's Position and Clarification
Pheton鈥檚 management team unequivocally and categorically denies any involvement in, or knowledge of, any form of stock price manipulation. At no point has the Company participated in, initiated, or sanctioned any rumor, communication, or activity regarding an acquisition by Gilead, or any other party. Pheton has had no contact with Gilead, and any statements or reports suggesting otherwise were and are entirely false and fabricated.
Additionally, Pheton plans to engage with its market makers, Nasdaq, and relevant regulatory bodies for the purpose of holding responsible parties to the scheme accountable.
Protecting Shareholder Interests
We recognize the concern this incident has caused among our investors, and we are monitoring internal controls and communications to ensure that any further misinformation can be swiftly and effectively countered.
Commitment to Transparency and Growth
Pheton is committed to upholding the highest standards of corporate governance, transparency, and accountability. As always, we remain focused on creating long-term shareholder value through carefully considered growth opportunities that align with our mission and strengthen our market position.
Pheton has built its foundation on trust, innovation, and value creation and remains confident in the strength of its underlying business, long-term strategy, and the dedication of its team.
A Word to Our Shareholders
We deeply value the trust our shareholders place in us. We will continue to keep the investor community informed with accurate and timely disclosures. Our leadership remains focused on operational execution and strengthening the integrity of our public market presence.
About Pheton Holdings Ltd
Founded in 1998, Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd. (鈥淏eijing Feitian鈥�), focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product, Beijing Feitian鈥檚 Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Pheton is committed to leveraging its products and services to establish a potential new standard of care across multiple malignant tumor applications. For more information, please visit:
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company鈥檚 current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as 鈥渁pproximates,鈥� 鈥渂elieves,鈥� 鈥渉opes,鈥� 鈥渆xpects,鈥� 鈥渁nticipates,鈥� 鈥渆stimates,鈥� 鈥減rojects,鈥� 鈥渋ntends,鈥� 鈥減lans,鈥� 鈥渨ill,鈥� 鈥渨ould,鈥� 鈥渟hould,鈥� 鈥渃ould,鈥� 鈥渕ay鈥� or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's filings with the U.S. Securities and Exchange Commission.
For investor and media inquiries, please contact:
Pheton Holdings Ltd
Investor Relations
Email:
Jackson Lin
Lambert by LLYC
Tel: +1 (646) 717-4593
Email:
###
FAQ
What caused Pheton Holdings (PTHL) stock price decline in July 2025?
Is Pheton Holdings being acquired by Gilead Sciences?
What actions is Pheton Holdings taking regarding the market manipulation allegations?
How is Pheton Holdings addressing shareholder concerns about the stock volatility?
What is Pheton Holdings' main business?
